Clark & Stuart, Inc has filed its 13F form on October 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $140 Billion distributed in 52 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Johnson & Johnson with a value of $9.63B, Merck & Co., Inc. with a value of $9.16B, New York Times CO with a value of $9.02B, 3 M CO with a value of $8.75B, and Fastenal CO with a value of $8.42B.

Examining the 13F form we can see an increase of $7.08B in the current position value, from $133B to 140B.

Clark & Stuart, Inc is based out at Portland, ME

Below you can find more details about Clark & Stuart, Inc portfolio as well as his latest detailed transactions.

Portfolio value $140 Billion
Industrials: $36 Billion
Consumer Defensive: $31.9 Billion
Healthcare: $25.5 Billion
Communication Services: $10 Billion
Basic Materials: $9.29 Billion
Energy: $7.47 Billion
Financial Services: $6.96 Billion
Technology: $5.36 Billion
Other: $7.43 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 52
  • Current Value $140 Billion
  • Prior Value $133 Billion
  • Filing
  • Period Q3 2025
  • Filing Date October 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 4 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Clark & Stuart, Inc Portfolio

Follow Clark & Stuart, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark & Stuart, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark & Stuart, Inc with notifications on news.